Highbridge Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-833
| Closed | -$287K | – | 625 |
|
|
2018
Q2 | $287K | Buy |
+833
| New | +$287K | 0.01% | 484 |
|
|
2018
Q1 | – | Sell |
-21,455
| Closed | -$8.07M | – | 1046 |
|
|
2017
Q4 | $8.07M | Buy |
+21,455
| New | +$8.07M | 0.14% | 157 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 1064 |
|
|
2017
Q1 | – | Sell |
-882
| Closed | -$323K | – | 1304 |
|
|
2016
Q4 | $323K | Buy |
+882
| New | +$323K | 0.01% | 769 |
|
|
2016
Q3 | – | Sell |
-13,893
| Closed | -$4.85M | – | 1292 |
|
|
2016
Q2 | $4.85M | Buy |
13,893
+12,557
| +940% | +$4.39M | 0.08% | 232 |
|
|
2016
Q1 | $481K | Buy |
+1,336
| New | +$481K | 0.01% | 552 |
|
|
2015
Q4 | – | Sell |
-3,266
| Closed | -$1.52M | – | 1070 |
|
|
2015
Q3 | $1.52M | Buy |
+3,266
| New | +$1.52M | 0.02% | 442 |
|
|
2014
Q3 | – | Sell |
-14,931
| Closed | -$4.22M | – | 972 |
|
|
2014
Q2 | $4.22M | Buy |
+14,931
| New | +$4.22M | 0.05% | 251 |
|
|
2014
Q1 | – | Sell |
-1,400
| Closed | -$385K | – | 862 |
|
|
2013
Q4 | $385K | Buy |
+1,400
| New | +$385K | ﹤0.01% | 521 |
|
|
2013
Q3 | – | Sell |
-33,367
| Closed | -$7.5M | – | 1088 |
|
|
2013
Q2 | $7.5M | Buy |
+33,367
| New | +$7.5M | 0.07% | 258 |
|